Donald Emil Ganem
Amministratore Delegato presso Via Nova Therapeutics, Inc.
Provenienza dei contatti di primo grado di Donald Emil Ganem
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Donald Emil Ganem tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
COLGATE-PALMOLIVE COMPANY | Household/Personal Care | Director/Board Member | |
CONAGRA BRANDS, INC. | Food: Major Diversified | President | |
PROCTER & GAMBLE COMPANY | Household/Personal Care | Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member | |
BLUE NILE INC | Specialty Stores | Director/Board Member | |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Stanford University | College/University | Undergraduate Degree | |
University of Oxford | College/University | Doctorate Degree | |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | President | |
University of Cambridge | College/University | Graduate Degree | |
Pinnacle Foods Group LLC
Pinnacle Foods Group LLC Food: Specialty/CandyConsumer Non-Durables Pinnacle Foods Group LLC operates as a producer, marketer, and distributor of shelf stable and frozen food products. Its products are sold through supermarkets, grocery wholesalers and distributors, mass merchandisers, convenience stores, warehouse clubs and military channels. The company was founded on June 19, 1998 and is headquartered in Parsippany, NJ. | Food: Specialty/Candy | Director/Board Member | |
Yale University | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree | |
Prospect Venture Partners
Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Heinz North America Consumer Products
Heinz North America Consumer Products Food: Specialty/CandyConsumer Non-Durables Heinz North America Consumer Products manufactures snack foods. Its products include mustard and barbecue and pasta sauces that are sold under the Heinz 57, Jack Daniels, Classico pasta sauces, and Lea & Perrins Worcestershire brands. The company is located in Pittsburgh, PA. | Food: Specialty/Candy | Chief Executive Officer | |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman | |
Pinnacle Foods Finance LLC
Pinnacle Foods Finance LLC Food: Major DiversifiedConsumer Non-Durables Pinnacle Foods Finance LLC produces and markets food products. The company was founded on March 5, 2007 and is headquartered in Parsippany, NJ. | Food: Major Diversified | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President | |
Novartis Consumer Health, Inc.
Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Pharmaceuticals: Major | Chief Executive Officer | |
GENERAL MOTORS COMPANY | Motor Vehicles | Director/Board Member | |
Heinz Europe Ltd. | Chief Executive Officer | ||
The Blackstone Group
The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | Investment Managers | Corporate Officer/Principal | |
QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Chairman | |
Aditum Bio Fund 1 LP
Aditum Bio Fund 1 LP Investment ManagersFinance Aditum Bio Fund 1 LP specializes in acquiring and developing pharmaceutical assets. The company is headquartered in San Mateo, CA. | Investment Managers | Director/Board Member | |
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Investment Managers | Chief Executive Officer | |
Aditum Bio Management Co. LLC
Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is a biotech venture capital company based in Oakland, CA. Aditum Bio is committed to improving public health by accelerating research and development in disease areas with both large and more targeted patient populations. The private company focuses on basic mechanisms of disease, in-license promising drug candidates, and spin-out individual companies dedicated to bringing each candidate through phase II clinical trials. In partnership with Trialspark, Aditum Bio uses data, software, and technology to help bring innovative medicines through the clinical trial phase more quickly and with lower costs than traditional pharmaceutical companies. The company was founded by Paul Sekhri, Joseph Jimenez, and Mark Fishman. | Investment Managers | Founder | |
Tempero Bio, Inc.
Tempero Bio, Inc. Pharmaceuticals: MajorHealth Technology Tempero Bio, Inc. engages in clinical development of mGlu5 NAM program in neurological diseases. The company is headquartered in Oakland, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Biotechnology | Director/Board Member Chief Executive Officer | |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 36 |
Regno Unito | 5 |
Svizzera | 5 |
Belgio | 2 |
Cina | 2 |
Settori
Health Technology | 19 |
Consumer Non-Durables | 8 |
Finance | 8 |
Consumer Services | 7 |
Commercial Services | 4 |
Posizioni
Director/Board Member | 26 |
Chief Executive Officer | 9 |
President | 6 |
Corporate Officer/Principal | 5 |
Independent Dir/Board Member | 5 |
Contatti più connessi
Insiders | |
---|---|
Joseph Jimenez | 32 |
Ilan Zipkin | 14 |
Benjamine Liu | 7 |
- Borsa valori
- Insiders
- Donald Emil Ganem
- Connessioni Società